Actos Lawsuit Details
Actos Lawsuit Details (6/13/12): A new study supports the existing and continued filing of Actos Lawsuit cases by those diagnosed with bladder cancer. For almost a year now, consumers of Actos have been warned through the FDA website that the use of Actos over the long-term may create an increased risk for bladder cancer. The latest study by the British Medical Journal was released at the end of May by researchers in Montreal at McGill University. Please read on for the details of this study and contact us for information regarding the Actos Lawsuit.
The results from the study add significant support for those pursuing an Actos Lawsuit claim. The findings for those taking Actos for a lengthy period of time of possible increased bladder cancer risks were in the percentage amount as high as 83.
Their study included more than 115,000 participants and linked the risk to those taking Actos and an increasing risk for those taking Actos more than two years. Prior to the study published in the British Medical Journal, there has been no proposal for why Actos creates a possible increased risk for bladder cancer. The findings of this study from McGill, highlighted a possible cause in the chronic irritation of the bladder from crystal formation caused by Actos. Further research is necessary to positively establish a link.
If you would like to learn how you can join the Actos Lawsuit, please contact us through this site today. We are connected with qualified attorneys who are actively pursuing the Actos Lawsuit.